FDA product code QXN: Suction Anti-Choking Device As A Second-Line Treatment

QXN is the FDA product code for suction anti-choking device as a second-line treatment. It is a Class II device, regulated under 21 CFR 874.5400 and reviewed by the Ear, Nose and Throat panel. Devices under QXN reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

A suction anti-choking device as a second-line treatment is intended to be used, by application of suction, to resolve choking in victims experiencing complete airway obstruction. The device is intended to be used as a second-line treatment in an emergency situation after unsuccessful use of a basic life support (BLS) choking protocol.

Classification

FieldValue
Device nameSuction Anti-Choking Device As A Second-Line Treatment
Device classClass II
Regulation21 CFR 874.5400
Review panelEN — Ear, Nose and Throat
Medical specialtyEar, Nose, Throat
Premarket route510(k)
Life-sustaining or supportingYes

Recalls for QXN devices

openFDA lists no recalls for product code QXN.

Frequently asked questions

What is FDA product code QXN?

QXN is the FDA product code for suction anti-choking device as a second-line treatment. It is a Class II device, regulated under 21 CFR 874.5400 and reviewed by the Ear, Nose and Throat panel.

What device class is QXN?

Class II, regulation 21 CFR 874.5400. Typical premarket route: 510(k).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Ear, Nose and Throat product codes · FDA product code lookup · 510(k) database search · 510(k) review times